XBIT — XBiotech Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1626878 ·
Last close
$2.34
Market Cap
$71.34M
52W High
$2.65
52W Low
$2.17
ADV30
27,253
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -6,274,000 | -5,505,000 | 139,836,000 | 115,459,000 | 4,819,000 |
| Dec 2025 | 0 | — | -29,755,000 | -26,892,000 | 150,082,000 | 125,551,000 | 9,732,000 |
| Sep 2025 | 0 | — | -6,047,000 | -6,008,000 | 172,424,000 | 147,367,000 | 5,344,000 |
| Jun 2025 | 0 | — | -6,336,000 | -1,756,000 | 178,682,000 | 152,938,000 | 5,618,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-42,169,000
Investing CF
$-186,000
Financing CF
$0
CapEx
$-289,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.80
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-141,882,000
Inventory
—
Receivables
$302,000
ST Investments
—
EBIT TTM
$-39,906,000
Pretax Income TTM
$-39,906,000
Interest Exp TTM
$0
Analysts
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -55,685,000 | -45,540,000 | 150,082,000 | 9,732,000 | — | -39,920,000 |
| Dec 2024 | 0 | -42,471,000 | -38,531,000 | 199,093,000 | 16,825,000 | — | -30,963,000 |
| Dec 2023 | 0 | -37,510,000 | -24,557,000 | 226,615,000 | 7,769,000 | — | -18,725,000 |
| Dec 2022 | 4,010,000 | -34,490,000 | -32,900,000 | 246,103,000 | 5,701,000 | — | -14,824,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.13
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| GANX | Gain Therapeutics, Inc. | $71.66M | $1.68 | — |
| BHST | BIOHARVEST SCIENCES INC. | $72.54M | $3.20 | — |
| PLRX | PLIANT THERAPEUTICS, INC. | $69.97M | $1.13 | — |
| HYFT | MindWalk Holdings Corp. | $72.87M | $1.56 | — |
| CYPH | CYPHERPUNK TECHNOLOGIES INC. | $69.20M | $0.65 | — |
News headlines (Yahoo Finance, 1h cache)
XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis
2026-06-15 13:00 · Yahoo
XBiotech: Q4 Earnings Snapshot
2026-03-13 20:16 · Yahoo
3 Promising Penny Stocks With Market Caps Over $30M
2025-12-19 18:05 · Yahoo
November 2025's Promising Penny Stocks To Watch
2025-11-12 18:05 · Yahoo
XBiotech: Q3 Earnings Snapshot
2025-11-12 16:55 · Yahoo
XBiotech Inc.'s (NASDAQ:XBIT) top owners are retail investors with 52% stake, while 36% is held by insiders
2025-08-28 10:04 · Yahoo
XBiotech: Q2 Earnings Snapshot
2025-08-13 18:55 · Yahoo
3 Promising Penny Stocks With Market Caps Above $90M
2025-07-02 18:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.